FA
Frances Arnold sold $185K of GENB stock
Frances Arnold, Dir of Generate Biomedicines, Inc. (GENB), sold 11,409 shares of GENB stock worth $185K, per an SEC Form 4 filed Nov 4, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 29, 2026, 6 days before it was made public.
GENB has moved -34.2% since the trade date, from $15.77 to $10.37 (Nov 19, 2026 close).
- Traded
- Oct 29, 2026
- Disclosed
- Nov 4, 2026
- Filing delay
- 6 days
- Price since
- -34.2%
- Role
- Dir
- Source
- SEC Form 4